Cargando…

Glucose dysregulation in pre-clinical Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Connolly, Niamh M. C., Theurey, Pierre, Pizzo, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710053/ https://www.ncbi.nlm.nih.gov/pubmed/31386625 http://dx.doi.org/10.18632/aging.102146

Ejemplares similares

The Aging Mitochondria
por: Theurey, Pierre, et al.
Publicado: (2018)

Systems biology identifies preserved integrity but impaired metabolism of mitochondria due to a glycolytic defect in Alzheimer's disease neurons
por: Theurey, Pierre, et al.
Publicado: (2019)

Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
por: Galla, Luisa, et al.
Publicado: (2020)

Dysregulation of Nitric Oxide Signaling in Microglia: Multiple Points of Functional Convergence in the Complex Pathophysiology of Alzheimer Disease
por: Stefano, George B., et al.
Publicado: (2020)

Calpain Dysregulation in Alzheimer's Disease
por: Ferreira, Adriana
Publicado: (2012)

Defective autophagy and Alzheimer’s disease: is calcium the key?
por: Filadi, Riccardo, et al.
Publicado: (2019)

Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease
por: Ando, Kunie, et al.
Publicado: (2021)

Clinical Neurophysiology in Alzheimer's Disease
por: Ferreri, Florinda, et al.
Publicado: (2011)

Dysregulating the regulators
por: Robertson, Miranda
Publicado: (2009)

Pre-disease pregnancy complications and systemic sclerosis: pathogenic or pre-clinical?
por: Chakravarty, Eliza
Publicado: (2012)

Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
por: Magi, Simona, et al.
Publicado: (2016)

Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
por: Yan, Xu, et al.
Publicado: (2020)

Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
por: Nanclares, Carmen, et al.
Publicado: (2021)

Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease
por: Onukwufor, John O., et al.
Publicado: (2022)

Emerging insights into synapse dysregulation in Alzheimer’s disease
por: Martínez-Serra, Raquel, et al.
Publicado: (2022)

Key Signalling Molecules in Aging and Neurodegeneration
por: Filadi, Riccardo, et al.
Publicado: (2022)

Early Clinical and Molecular Detection of Alzheimer's Disease
por: Nacmias, Benedetta, et al.
Publicado: (2011)

Applications of Alzheimer’s disease staging to clinical trials
por: Therriault, Joseph, et al.
Publicado: (2023)

Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic Alzheimer’s disease
por: Huang, Chia-Wei, et al.
Publicado: (2022)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
por: Li, Min, et al.
Publicado: (2021)

Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
por: Yang, Alex J. T., et al.
Publicado: (2021)

Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
por: Snow, Wanda M., et al.
Publicado: (2016)

Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer’s Disease
por: Arnst, Nikita, et al.
Publicado: (2022)

Sporadic Alzheimer’s Disease Begins as Episodes of Brain Ischemia and Ischemically Dysregulated Alzheimer’s Disease Genes
por: Pluta, Ryszard, et al.
Publicado: (2013)

Hallmarks of human “immunosenescence”: adaptation or dysregulation?
por: Pawelec, Graham
Publicado: (2012)

Chromatin dysregulation by mutant p53
por: Pfister, Neil T., et al.
Publicado: (2016)

Asthma and the Dysregulated Immune Response to Rhinovirus
por: Wark, Peter A. B.
Publicado: (2020)

Dysregulated Wnt Signalling in the Alzheimer’s Brain
por: Aghaizu, Nozie D., et al.
Publicado: (2020)

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease()
por: Dunn, Laura, et al.
Publicado: (2014)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Could autophagy dysregulation link neurotropic viruses to Alzheimer’s disease?
por: Romeo, Maria Anele, et al.
Publicado: (2019)

Mechanisms Underlying Dysregulation of miR-132 in Alzheimer’s Disease
por: Song, Qiaoyun, et al.
Publicado: (2019)

Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes
por: Liu, Yue, et al.
Publicado: (2021)

Into the Fourth Dimension: Dysregulation of Genome Architecture in Aging and Alzheimer’s Disease
por: Winick-Ng, Warren, et al.
Publicado: (2018)

Dysregulation of Endothelin-1: Implications for Health Disparities in Alzheimer’s Disease
por: Alcendor, Donald J.
Publicado: (2020)

Metals and Alzheimer's Disease
por: White, Anthony R., et al.
Publicado: (2011)

Care for Alzheimer's Disease
por: Umegaki, Hiroyuki, et al.
Publicado: (2013)

Microglia in Alzheimer's Disease
por: Jin, Lee-Way
Publicado: (2012)

ASM in Alzheimer's disease
por: Lee, Jong Kil, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q47b1glecu8o7vnnq8pbf9to5q